| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.38 | 0.03 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |